It is interesting to point out, however, that AR is known to upregulate the expression of p21CIP1, a well-known inhibitor of cyclin-dependent kinases, in prostate cancer cell lines, including the ones tested in this study [33]. Here, CDKN1A is linked to prostate cancer.